Startups in Foodtech
Iqm
IQM is a global leader in building quantum computers. IQM provides on-premises quantum computers for supercomputing centres, enterprises, and research labs and offers full access to its hardware. IQM also has a quantum computing cloud offering “IQM Resonance.” IQM’s commercial quantum computers include Finland’s ongoing commercial 50-qubit quantum computer co-development project with VTT, IQM-led consortium’s (Q-Exa) HPC quantum accelerator in Germany, and IQM processors will also be used in the first quantum accelerator in Spain. IQM has over 300+ employees, with offices in Espoo, Madrid, Munich, Palo Alto, Paris, Singapore, and Warsaw.
Space Forge
Space Forge is a global company looking to lead the clean industrial revolution by harnessing space. Space Forge Ltd operates from headquarters in the UK, and through its independent entity, Space Forge US. We are developing fully reusable satellites that are designed for manufacturing next generation super materials in space for return to Earth to be used to help move to low carbon technologies.
Diamfab
At DIAMFAB we synthesize diamond for the semiconductor industry. Our products will be at the heart of the energy transition thanks to their superior electrical performance, record efficiency and high compactness. From the electric car to the future high voltage network, from hybrid aircraft to batteries for connected objects, diamond will be the key to the electrification of our society.
Cambridge GaN Devices
Cambridge GaN Devices Ltd. (CGD), a spin-out of the Cambridge University, is a fabless semiconductor company designing, developing and commercialising energy-efficient GaN-based power devices to make greener electronics possible. As a change maker, CGD introduced ICeGaN™ - an industry-first enhancement-mode (eMode) GaN transistor which can be operated like a Silicon MOSFET without the need for special gate drivers, driving circuitry, or unique gate voltage clamping mechanisms. The company has launched H1 & H2 Series. Learn more information, please visit at www.camgandevices.com. Follow Cambridge GaN Devices on Facebook, Twitter, Instagram, YouTube and 剑桥氮化镓器件 on WeChat.
Ogni
Ogni offers an AI-powered platform that identifies essential compliance requirements and integrates them with practical security and business measures. Designed for growing European companies and non-EU businesses entering the EU market, our solution streamlines cybersecurity compliance by mapping regulatory needs to existing security practices. This approach minimizes unnecessary effort while closing critical compliance gaps.
Zenride
Boostez votre marque employeur avec un nouvel avantage social : le vélotaf par Zenride. Le vélotaf est un avantage social gratuit pour les employeurs qui permet aux salariés de rouler avec le vélo de leur rêve en économisant au moins 30%. Le vélotaf, c’est l’avantage qui a beaucoup d’avantages : - Attirez les meilleurs talents - Fidélisez vos employés - Réduisez l’absentéisme - Réduisez votre empreinte carbone - Faites des économies de parking Saint-Gobain, Safran, Veolia, Caisse d’Epargne, Allianz et plus de 500 autres employeurs grands groupes, ETI et PME ont déjà fait le choix de se démarquer en adoptant le vélotaf. Découvrez ce nouvel avantage social et ses bénéfices sur notre site internet www.zenride.co
ZeroIN
ZeroIN, expanding the frontiers of sweets with functional & natural sweeteners. We want to push the boundaries of sugar substitutes to the next level.
Zymoptiq
ZYMOPTIQ is a company offering a disruptive analytic tool to characterize, measure and assay the enzymes activities in a very fast, simple and cheap way. ZYMOPTIQ's enzymatic products are ready to use and very user friendly. ZYMOPTIQ is the new analytical solution to perform enzymatic tests in the most efficient way!
Nūmi
At Nūmi, we're on a mission to redefine infant health through groundbreaking research and innovations. We’re working to recreate the magic of in vivo breast milk in vitro, offering parents a natural choice when breastfeeding isn’t an option, offering a natural alternative for parents unable to breastfeed and aiming to improve infant nutrition and health.
Xenium Cloud Technologies
Scaling your business shouldn’t mean drowning in cloud bills or hiring expensive DevOps teams. Yet every day, companies like yours waste time and money fixing infrastructure fires instead of focusing on growth. Let’s change that!
You already know the struggle:
🚧 Scaling your high traffic/AI workloads = skyrocketing cloud costs
🚧 DevOps hiring = time-consuming, expensive
🚧 Deployments = slow, error-prone across staging , production incidents, unhappy customers
That’s why we built XePlatform, Platform Engineering as a Product!
🔥 XeInfra →
• Provision Kubernetes stacks with flawless automation.
• Slash setup time by 80% — no more “environment drift” surprises.
🚀 XeRelease →
• GitOps-based Golden Paths — standardise workflows that balance speed and governance.
• Nothing ships untested — automated safety nets baked into every release.
• Single-click deployments cut cycles by 70% — even for AI model pipelines.
🔍 XeObserve →
• Predictive monitoring slashes MTTR by 90%.
• Cost dashboards spotlight wastage in cloud resources — like a CFO built them.
The result? Your development team ships 5x faster while cutting cloud spend by up to 80%—with production-ready infrastructure from Day 1.
✅ Spin up Kubernetes infrastructure in minutes.
✅ Deploy workloads at lightning speed
Vinghen
At Vinghen we develop the future of urban micro-mobility. We focus on electric bicycles and scooters with distinctive design, engaging ride, and wide customization options.
Phenaros Pharmaceuticals
Phenaros Pharmaceuticals is a Swedish spin-off from Uppsala University, focused on transforming drug discovery through a cutting-edge AI-first platform. Specializing in phenomics, the company combines large-scale cell morphological profiling with AI and automation to accelerate the identification and repurposing of drugs, particularly for rare diseases. Phenaros’ approach utilizes Cell Painting, a method of detailed, high-content imaging of cells, to capture unique cellular signatures. These profiles enable predictions of a drug’s mechanism of action, target identification, and cellular toxicity.
The company’s platform is powered by a robust AI engine that processes vast amounts of data generated by automated experiments. This AI-driven methodology significantly enhances the speed, efficiency, and safety of the drug discovery process, bypassing the traditional, slow-paced methods. In addition to its own drug discovery pipeline, Phenaros collaborates with pharma and biotech companies, providing them with access to its innovative discovery platform.
Phenaros is committed to automating data collection and leveraging it as a key asset to continually improve its AI algorithms. Their unique, integrated approach leads to faster and more efficient drug development, helping bring treatments to market with fewer resources. By focusing on rare diseases, Phenaros addresses a significant unmet medical need while also aiming to transform the way drug discovery is conducted globally.